Jessica Meng
Vermögen: 4 Mio $ am 31.05.2026
Vermögen: 4 Mio $ am 31.05.2026
Jessica Meng is Chief Commercial Officer at CareDx, Inc. since 2024.
Former roles include Vice President-Marketing at Veracyte, Inc. from 2018 to 2020 and Chief Commercial Officer at Delfi Diagnostics, Inc. Education includes an undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CAREDX, INC. 0,33 % | 01.04.2026 | 169 392 ( 0,33 % ) | 4 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CAREDX, INC. | Corporate Officer/Principal | 12.09.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| VERACYTE, INC. | Vertrieb & Marketing | 01.05.2020 |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops non-invasive blood test for detection and interception of cancer | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen